Specific alterations in the retinal microstructure in neovascular age-related macular degeneration under anti-VEGF therapy

被引:0
作者
Schneiderbauer, T. [1 ]
Ahlers, C. [1 ]
Stock, G. [1 ]
Golbaz, I. [1 ]
Schuetze, C. [1 ]
Sacu, S. [1 ]
Schmidt-Erfurth, U. [1 ]
机构
[1] Med Univ Wien, Univ Klin Augenheilkunde & Optometrie, A-1090 Vienna, Austria
来源
OPHTHALMOLOGE | 2011年 / 108卷 / 01期
关键词
Age-related macular degeneration; Optical coherence tomography (OCT); High-resolution OCT; Ranibizumab; Retinal layers; OPTICAL COHERENCE TOMOGRAPHY; RANIBIZUMAB; EYE;
D O I
10.1007/s00347-010-2182-z
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
High-definition raster scanning spectral-domain optical coherence tomography (SD-OCT) allows a precise assessment of retinal layers and a more detailed detection of subtle morphological alterations. The aim of this study was to observe such changes in patients with neovascular age-related macular degeneration (nAMD) under anti-VEGF therapy and to evaluate if they show characteristic and reversible properties. The study included 20 consecutive patients with untreated nAMD. SD-OCT with an axial resolution of 6 A mu m and a scan velocity of up to 25,000 A-scans/s was used for high-resolution imaging of the macular region at baseline and at months 1 and 3. Characteristic changes in the retinal microstructure were documented and analyzed. Obvious morphological changes as well as discrete intraretinal alterations showed a clear improvement until the third month following the initial ranibizumab injection. Destructions of the neurosensory retina and the outer retinal layers were partly reversible and significantly reduced after treatment was applied. SD-OCT was able to detect additional information on specific morphological alterations within the retina. These changes showed a considerable reduction under consistent treatment indicating their potential value for monitoring treatment success in antiangiogenic strategies.
引用
收藏
页码:38 / +
页数:7
相关论文
共 16 条
[1]   New perspectives in diagnostics. High-resolution optical coherence tomography for age-related macular degeneration [J].
Ahlers, C. ;
Geitzenauer, W. ;
Simader, C. ;
Stock, G. ;
Golbaz, I. ;
Polak, K. ;
Georgopoulo, M. ;
Schmidt-Erfurth, U. .
OPHTHALMOLOGE, 2008, 105 (03) :248-254
[2]  
Ahlers Christian, 2008, Ophthalmology, V115, pe39, DOI 10.1016/j.ophtha.2008.05.017
[3]   Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study [J].
Brown, David M. ;
Michels, Mark ;
Kaiser, Peter K. ;
Heier, Jeffrey S. ;
Sy, Judy P. ;
Ianchulev, Tsontcho .
OPHTHALMOLOGY, 2009, 116 (01) :57-65
[4]   Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999 [J].
Coleman, Anne L. ;
Yu, Fei .
OPHTHALMOLOGY, 2008, 115 (01) :18-25
[5]   Morphologic changes in acute central serous chotioretinopathy evaluated by Fourier-domain optical coherence tomography [J].
Fujimoto, Hisataka ;
Gomi, Fumi ;
Wakabayashi, Taku ;
Sawa, Miki ;
Tsujikawa, Motokazu ;
Tano, Yasuo .
OPHTHALMOLOGY, 2008, 115 (09) :1494-1500
[6]   An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration [J].
Fung, Anne E. ;
Lalwani, Geeta A. ;
Rosenfeld, Philip J. ;
Dubovy, Sander R. ;
Michels, Stephan ;
Feuer, William J. ;
Puliafito, Carmen A. ;
Davis, Janet L. ;
Flynn, Harry W., Jr. ;
Esquiabro, Maria .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (04) :566-583
[7]   Relationship Between Optical Coherence Tomography Retinal Parameters and Visual Acuity in Neovascular Age-Related Macular Degeneration [J].
Keane, Pearse A. ;
Liakopoulos, Sandra ;
Chang, Karen T. ;
Wang, Mingwu ;
Dustin, Laurie ;
Walsh, Alexander C. ;
Sadda, Srinivas R. .
OPHTHALMOLOGY, 2008, 115 (12) :2206-2214
[8]  
KLEIN R, 1992, OPHTHALMOLOGY, V99, P933
[9]   Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation [J].
Moutray, T. ;
Alarbi, M. ;
Mahon, G. ;
Stevenson, M. ;
Chakravarthy, U. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (03) :361-364
[10]   Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431